Skip to main content
Clinical Trials/IRCT2014060115963N2
IRCT2014060115963N2CompletedPhase 3

Efficacy of the prophylactic dose of Tranexamic acid on the amount of bleeding in jaw surgeries :a prospective randomized double blind clinical trial study

Guilan University of Medical Sciences Research Vice0 sites90 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
90

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 40 years (—)
Sex
All

Inclusion Criteria

  • Patients candidate for jaw fractures surgery (18-40yr);
  • ASA c lass I, II
  • Exclusion criteria:
  • History of Hemorrhagic Disease; thrombosis; Drugs That affect on the surgical Homeostasis; Anemia (Hematochrite <30);history of head injury ;intra cranial hematoma
  • ; drug sensitivity to Tranexamic acid

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Guilan University of Medical Sciences Research Vice

Similar Trials